Get started
Author

Daan Dierickx

Observed names: D Dierickx, D. Dierickx, D.D. Dierickx, DIERICKX D, Dierickx Daan, Dierickx, Daan
Observed institutions: Novartis (Switzerland), Tufts Medical Center, Mayo Clinic, Tel Aviv University, Georgetown University, University of Milan, University of Münster, Tel Aviv Sourasky Medical Center, Universitair Ziekenhuis Leuven, Hammersmith Hospital, Meir Medical Center, Erasmus MC, University of Oxford, University Hospital Schleswig-Holstein, IMEC, Royal Marsden Hospital, Sciensano (Belgium), DIAKO, Georgetown Lombardi Comprehensive Cancer Center, European Institute of Oncology, University of Duisburg-Essen, Charité - Universitätsmedizin Berlin, University of Brescia, Ludwig-Maximilians-Universität München, Amsterdam UMC Location Vrije Universiteit Amsterdam, KU Leuven
ORCID: 0000-0002-8917-022X
Observed ORCID: 0000-0002-8917-022X
OpenAlex ID: A5033063736
Stromal Gene Signatures in Large-B-Cell Lymphomas
2008 · G. Lenz, G. Wright, et al. · New England Journal of Medicine · 1,815
PDF
Post-Transplantation Lymphoproliferative Disorders in Adults
2018 · Daan Dierickx, Thomas M. Habermann · New England Journal of Medicine · 483
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015 · Vito Annese, Laurent Beaugerie, et al. · Journal of Crohn s and Colitis · 428
PDF
Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma
2018 · Ruzena Stranska, Laurens Gysbrechts, et al. · Journal of Translational Medicine · 399
PDF
Clinicopathologic Comparison of Plasmablastic Lymphoma in HIV-positive, Immunocompetent, and Posttransplant Patients
2014 · Julie Morscio, Daan Dierickx, et al. · The American Journal of Surgical Pathology · 266
PDF
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
2017 · Ralf U. Trappe, Daan Dierickx, et al. · Journal of Clinical Oncology · 227
PDF
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing
2015 · Frédéric Amant, Magali Verheecke, et al. · JAMA Oncology · 217
Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease
2015 · Christopher J. Hawkey, Matthieu Allez, et al. · JAMA · 189
PDF
Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era
2013 · A.M. Evens, S. Choquet, et al. · American Journal of Transplantation · 189
PDF
How I treat posttransplant lymphoproliferative disorders
2015 · Daan Dierickx, Thomas Tousseyn, et al. · Blood · 157
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study
2015 · Peter Vandenberghe, Iwona Wlodarska, et al. · The Lancet Haematology · 144
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors
2013 · Daan Dierickx, Thomas Tousseyn, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 134
PDF
Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas
2008 · Iwona Wlodarska, Daan Dierickx, et al. · Blood · 130
PDF
Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders
2013 · J. Morscio, D. Dierickx, et al. · American Journal of Transplantation · 120
Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting
2015 · Michael Lishner, Irit Avivi, et al. · Journal of Clinical Oncology · 116
PDF
Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?
2013 · J. Morscio, D. Dierickx, et al. · Clinical and Developmental Immunology · 109
PDF
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions
2010 · K. Van Roosbroeck, J. Cools, et al. · Haematologica · 105
PDF
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial
2017 · James O Lindsay, Mathieu Allez, et al. · ˜The œLancet. Gastroenterology & hepatology · 104
PDF
Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern
2015 · J. F. Ferreiro, J. Morscio, et al. · Haematologica · 98
PDF
EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features
2016 · J. Finalet Ferreiro, J. Morscio, et al. · American Journal of Transplantation · 95
PDF
G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells
2012 · Ariane Luyckx, Elio Schouppe, et al. · Clinical Immunology · 95
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
2024 · Kris Michael Mahadeo, Robert Baiocchi, et al. · The Lancet Oncology · 92
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma
2018 · Jorge J. Castillo, Thomas Guerrero‐Garcia, et al. · British Journal of Haematology · 92
PDF
Myeloablative Conditioning Predisposes Patients forToxoplasma gondiiReactivation after Allogeneic Stem Cell Transplantation
2010 · Stef Meers, Katrien Lagrou, et al. · Clinical Infectious Diseases · 85
Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies
2021 · Liesbeth Lenaerts, Nathalie Brison, et al. · EClinicalMedicine · 82
PDF
Works count: 349
Citation count: 8,977
H-index: 45
I10-index: 102
Year
Topic
Type